Racial Disparities in Diagnosis and Management of Benign Prostatic Hyperplasia: A Review
- 11 October 2022
- journal article
- review article
- Published by Springer Nature in Current Urology Reports
- Vol. 23 (11) , 297-302
Abstract
Purpose of Review We sought to perform a contemporary literature review highlighting the racial disparities which exists in the evaluation and management of benign prostatic hyperplasia (BPH). Recent Findings Current literature suggests that racial disparities exist in the diagnosis of BPH and treatment lower urinary tract symptoms (LUTS). This is seen in the presentation and diagnosis of the disease as well as a difference in preventative care with discordant incidences of medical and surgical management among racial groups. Summary The racial disparities that exist in the diagnosis and management of BPH and LUTS require further investigation to better identify the underlying causes. This will ultimately allow for continued improvement in care delivery and a more personalized approach in patient management.Keywords
This publication has 52 references indexed in Scilit:
- Obesity and Benign Prostatic Hyperplasia: Clinical Connections, Emerging Etiological Paradigms and Future DirectionsJournal of Urology, 2013
- The State of Research on Racial/Ethnic Discrimination in The Receipt of Health CareAmerican Journal of Public Health, 2012
- The crossroads of evidence-based medicine and health policy: implications for urologyWorld Journal of Urology, 2011
- Drug treatment of urological symptoms: estimating the magnitude of unmet need in a community‐based sampleBJU International, 2009
- The Relationship between Prostate Inflammation and Lower Urinary Tract Symptoms: Examination of Baseline Data from the REDUCE TrialEuropean Urology, 2008
- Pathology of benign prostatic hyperplasiaInternational Journal Of Impotence Research, 2008
- Race and Socioeconomic Status are Independently Associated With Benign Prostatic HyperplasiaJournal of Urology, 2008
- The role of estrogens and estrogen receptors in normal prostate growth and diseaseSteroids, 2008
- Metabolic Factors Associated with Benign Prostatic HyperplasiaThe Journal of Clinical Endocrinology & Metabolism, 2006
- Transforming growth factor-? is an autocrine mitogen for a novel androgen-responsive murine prostatic smooth muscle cell line, PSMC1Journal of Cellular Physiology, 2000